WebSimilarly, Inovio Pharmaceuticals, Inc. (Inovio) faces a class action in Pennsylvania for allegedly making false and misleading statements under the US Securities Exchange Act. The Claimants allege that Inovio and its CEO capitalized on widespread COVID-19 fears when the CEO falsely claimed Inovio had developed a vaccine for COVID-19. WebFeb 16, 2024 · A putative class of shareholders allege Inovio Pharmaceuticals, Inc. and three individual Defendants made false or misleading statements about Inovio's COVID-19 …
McDermid v. Inovio Pharm., Inc. - Casetext
WebMar 24, 2024 · Mar 24, 2024, 15:45 ET. BERWYN, Pa., March 24, 2024 /PRNewswire/ -- RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased Inovio ... WebAug 26, 2024 · Inovio Pharmaceuticals has agreed to settle a shareholder class action lawsuit, which alleged the Plymouth Meeting biotech company made "false and … contact zaxby\u0027s corporate
Inovio Embroiled in Lawsuits Around Its Potential COVID-19 Vaccine
WebMar 17, 2024 · Inovio Pharmaceuticals and its top officer have been hit with a proposed class action that alleges the parties issued materially false and misleading statements … WebI wrote to legal firm handling the referenced class action suit as I am unable to determine whether a loss must have occurred to receive potential settlement. RE: Civ. Action No. 2:20-cv-01402-GJP I purchased shares of … WebINOVIO PHARMACEUTICALS, INC., et al., Defendants. ) ) ) ) ) ) ) Civ. Action No. 2:20-cv-01402-GJP CLASS ACTION PROOF OF CLAIM To be eligible to receive a share of the Net Settlement Fund in connection with the Settlement of this Action, you must complete and sign this Proof of Claim Form (“Claim Form”) and mail it by first-class mail to the efes manchester